ILIM Indexed (Ireland) Financial Diagnostics

IE00B6550V21 -- Ireland Fund  

EUR 1.64  0.06  3.53%

The current investor indifference towards the small price fluctuations of ILIM Indexed may raise some interest from investors. The Fund closed today at a share price of 1.64 on 1.000 in trading volume. The fund managers did not add any value to ILIM Indexed Global Eq C Acc investors in February. However, most investors can still diversify their portfolios with ILIM Indexed to hedge your portfolio against high-volatility market scenarios. The fund standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Fund volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about ILIM Indexed as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis ILIM Indexed price relationship with some important fundamental indicators such as market cap and management efficiency. Please also check Risk vs Return Analysis.

ILIM Indexed Note

It is possible that ILIM Indexed Global Eq C Acc fund was delisted, renamed or otherwise removed from the exchange.

ILIM Indexed Global Alerts

ILIM Indexed Global is not yet fully synchronised with the market data
ILIM Indexed Global may become a speculative penny stock

ILIM Indexed Technical and Predictive Indicators

Did you try this?

Run Equity Search Now


Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Equity Search

Also Currentnly Active

Purchased over 20 shares of
a day ago
Traded for 117.63
Purchased over 400 shares of
a day ago
Traded for 6.39
Purchased over 40 shares of
a day ago
Traded for 65.83
Please also check Risk vs Return Analysis. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.